Blackfynn and Children's Hospital of Philadelphia said they have expanded their relationship. Under the expanded relationship, Blackfynn's Data Platform will be used by CHOP and the Children's Brain Tumor Tissue Consortium to bring together complex non-identifiable patient data for collaboration and analysis, thereby accelerating translational discovery toward treatments for brain cancer in children.
The new Cleveland Clinic Taussig Cancer Center will begin welcoming patients March 6.
Jeffrey Patrick was named director of the Drug Development Institute at The Ohio State University Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
Tony Hunter, who holds an American Cancer Society Professorship at the Salk Institute, has been awarded $500,000 as part of the $1 million Royal Swedish Academy of Sciences' inaugural Sjöberg Prize for Cancer Research for “groundbreaking studies of cellular processes that have led to the development of new and effective cancer drugs.”
The Prostate Cancer Foundation announced Tuesday it has granted eight new 2016 PCF Challenge Awards to advance treatments and cures for metastatic or currently incurable prostate cancer.
Chyke DoubeniMelissa SimonMichael BarryThe U.S. Preventive Services Task Force announced on Monday the addition of three new members: Chyke Doubeni, Melissa Simon and Michael Barry. They are appointed to serve four-year terms beginning in January 2017.
BTG plc announced a collaboration with the Society of Interventional Oncology, a global organization working to nurture and support interventional oncology worldwide, to explore the role of interventional oncology alongside immuno-oncology.
Perthera Inc. announced its partnership with Hope for Stomach Cancer, a patient-focused nonprofit that provides support, resources, and awareness to those facing stomach cancer. Perthera's Precision Cancer Analysis service will be available to all Hope for Stomach Cancer patients at no cost to them.
RPRD Diagnostics announced a collaboration with Children's Minnesota dedicated to implementing a pharmaco-genomic testing process.
Jeffery Kutok was named chief scientific officer at Infinity Pharmaceuticals.
